Altrova Health Announces Launch of O-Spray Product Line and Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: SSPLF) (FSE: QM4) ("Altrova Health" or the "Company") today announced the introduction of O-Spray™, a needle-free sublingual oral spray dosage format designed as an alternative to self-injection, pill, and syringe-based administration. O-Spray is positioned across current and future therapeutic areas including weight management, erectile dysfunction, menopause-related care, and other indications where an oral spray format may be appropriate.